Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 14,042 $ 22,563
Accounts receivable 59 109
Inventory, current 488 496
Prepaid expenses and other current assets 781 793
Total current assets 15,370 23,961
Fixed assets, net 1,325 1,428
Inventory, non-current 511
Right-of-use assets 428 687
Other non-current assets 13 13
Total assets 17,647 26,089
Current liabilities:    
Accounts payable and accrued expenses 1,969 2,584
Operating lease liabilities - current 245 307
Other current liabilities 53 10
Current portion of long-term debt, net of unamortized debt discount of $182 and $271, respectively 2,532 431
Total current liabilities 4,799 3,332
Contingent royalty obligation 1,212 1,760
Operating lease liabilities - non-current 178 385
Convertible note, net of unamortized debt discount of $108 and $166, respectively 3,892 3,834
Long-term debt, net of unamortized debt discount of $135 and $317, respectively 4,589 7,121
Total liabilities 14,670 16,432
Commitments and contingent liabilities (Note 9)
Shareholders’ equity    
Preferred stock $0.0001 par value; 10,000,000 shares authorized; zero shares issued and outstanding
Common stock $0.0001 par value; 115,000,000 shares authorized; 4,659,769 and 2,416,021 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively
Additional paid-in capital 144,328 132,411
Accumulated deficit (141,351) (122,754)
Total shareholders’ equity 2,977 9,657
Total liabilities and shareholders’ equity $ 17,647 $ 26,089